Life Sciences Partners Founded 1998
Founders Clemens Van Blitterswijk Rudy Dekeyser
Overview
Portfolio analytics
Team
Investments
News & Media
Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 71
Average round size
info
The average size of a deal this fund participated in
$22M
Portfolio companies 71
Rounds per year 3.09
Lead investments 39
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.34
Exits -
Key employees -
Areas of investment
Biotechnology
Finance
Health Care
Summary

The venture was found in Europe in The Netherlands. The main office of represented VC is situated in the Amsterdam.

The fund was created by Clemens Van Blitterswijk, Rudy Dekeyser. The overall number of key employees were 10.

Opposing the other organizations, this Life Sciences Partners works on 4 percentage points more the average amount of lead investments. The top activity for fund was in 2007. Despite it in 2019 the fund had an activity. Speaking about the real fund results, this VC is 18 percentage points more often commits exit comparing to other organizations. The fund is generally included in 2-6 deals every year. The usual things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2014.

The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Life Sciences Partners, startups are often financed by Kurma Partners, Idinvest Partners, VI Partners AG. The meaningful sponsors for the fund in investment in the same round are Ysios Capital, Idinvest Partners, Johnson & Johnson Development Corporation. In the next rounds fund is usually obtained by Novartis Venture Fund, LSP BioVentures, Gimv.

For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. The fund has specific favorite in a number of founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. We can highlight the next thriving fund investment areas, such as Therapeutics, Biopharma. Among the various public portfolio startups of the fund, we may underline Santarus, Hyperion Therapeutics, Merus Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.

Read more
Latest deals
CompanyIndustryRoundRound SizeDateInvestorsLocation
ViCentra
Health Care
Medical
Medical Device
Series B
10M20 Jan 2016 Netherlands, Utrecht
Rainier Therapeutics
Biopharma
Biotechnology
Developer Platform
Medical
Therapeutics
Series B
20M09 May 2018 United States, San Leandro
BioXell
Association
Biotechnology
Education
Medical
Series B
17M21 May 2003 Italy, Milan
PamGene
Biotechnology
Clinical Trials
Therapeutics
Series A
6M22 Dec 2000 Netherlands, 's-Hertogenbosch
Alizé Pharma
Biotechnology
Health Care
Medical
Pharmaceutical
Wellness
Series A
67M31 Jul 2019 France, Écully
Cardiac Dimensions
Biotechnology
Health Care
Medical Device
Series C
17M29 Sep 2020 Canada, Kirkland
OneProjects
Health Care
Medical Device
Series A
11M23 Jun 2020 Ireland, Dublin
Promethera Biosciences
Biotechnology
Pharmaceutical
Therapeutics
Series A
7M02 Feb 2010 Belgium, Mont-Saint-Guibert
BMEYE
Biotechnology
Health Care
Medical
Medical Device
Test and Measurement
Series A
01 Jan 2009 Netherlands, Amsterdam
Xeltis
Health Care
Medical Device
Therapeutics
Series B
3M17 Dec 2015 Switzerland, Zurich
Review
  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Life Sciences Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: